We have located links that may give you full text access.
ENGLISH ABSTRACT
JOURNAL ARTICLE
[In vivo tissue distribution of laryngeal cancer drained lymph node lymphocytes in tumor-bearing mice].
The distribution of 3H-TdR labeled human laryngeal cancer drained lymph node lymphocytes (LNL) to human laryngeal squamous cell carcinoma were traced in PHC3 bearing nude mice, and the radioactivity in tissues was detected. 30.7% labeled cells were localized in live in first day after transfer, and a few in lung, spleen and kidney. Labeled cells were reduced weekly and by the end of the fourth week there were still 4.3% in live, but very few were detected in the tumor site. This indicated that cancer drained LNL had no specificity to tumor, and could not infiltrate into tumor sites. So besides directly attacking tumor cells in vivo, possibly, there are some indirect mechanisms to mediate tumor regression.
Full text links
Related Resources
Trending Papers
Heart failure with preserved ejection fraction: diagnosis, risk assessment, and treatment.Clinical Research in Cardiology : Official Journal of the German Cardiac Society 2024 April 12
Proximal versus distal diuretics in congestive heart failure.Nephrology, Dialysis, Transplantation 2024 Februrary 30
World Health Organization and International Consensus Classification of eosinophilic disorders: 2024 update on diagnosis, risk stratification, and management.American Journal of Hematology 2024 March 30
Efficacy and safety of pharmacotherapy in chronic insomnia: A review of clinical guidelines and case reports.Mental Health Clinician 2023 October
Get seemless 1-tap access through your institution/university
For the best experience, use the Read mobile app
All material on this website is protected by copyright, Copyright © 1994-2024 by WebMD LLC.
This website also contains material copyrighted by 3rd parties.
By using this service, you agree to our terms of use and privacy policy.
Your Privacy Choices
You can now claim free CME credits for this literature searchClaim now
Get seemless 1-tap access through your institution/university
For the best experience, use the Read mobile app